share_log

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A:持股變動聲明(修正)-高管 Dogan Timur
美股SEC公告 ·  2024/09/24 04:29

牛牛AI助理已提取核心訊息

Cardio Diagnostics Holdings, Inc. (CDIO.US) reported that its Chief Technology Officer, Dogan Timur, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Timur's direct holdings in the company increased to a total of 197,310 shares. The transaction is part of an open market or private purchase, as per the announcement.
Cardio Diagnostics Holdings, Inc. (CDIO.US) reported that its Chief Technology Officer, Dogan Timur, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Timur's direct holdings in the company increased to a total of 197,310 shares. The transaction is part of an open market or private purchase, as per the announcement.
Cardio Diagnostics Holdings, Inc.(CDIO.US)報告稱,其首席技術官Dogan Timur於2024年9月6日完成了對公司股票的購買。該交易涉及以0.29美元的價格購買68,965股普通股。在此次交易之後,Timur在公司的直接持股增加至總共197,310股。根據公告,該交易是市場公開或者私人購買的一部分。
Cardio Diagnostics Holdings, Inc.(CDIO.US)報告稱,其首席技術官Dogan Timur於2024年9月6日完成了對公司股票的購買。該交易涉及以0.29美元的價格購買68,965股普通股。在此次交易之後,Timur在公司的直接持股增加至總共197,310股。根據公告,該交易是市場公開或者私人購買的一部分。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。